Partner Content Partner Content 3rd Annual AI-ML Drug Discovery & Development Summit Discover Case Studies of Machine Learning in Action
Partner Content Partner Content Understanding the evolving CAR-T market In August 2017, Novartis made history after receiving FDA approval for Kymriah, the world’s first chimeric antigen receptor T-cell (CAR-T) therapy.
News BioNTech and Vir prepare mega-IPOs after flurry of launches Two of the largest-ever biotech initial public offerings (IPOs) are scheduled to go ahead in the coming week, after a flurry of smaller stock market launches last week.
Events Partner Content J+D Forecasting bring their Face-to-Face Pharma training to ... Face-to-Face Pharma Forecasting Training in Boston
Events Partner Content J+D Forecasting bring their Oncology Forecasting Training to... Oncology Forecasting Training In Boston by J+D Forecast
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
